Product Name | Enfuvirtide Acetate (T-20) | Sequence | CH3CO-Tyr-Thr-Ser-Leu-Ile-His-Ser-Leu-Ile-Glu
-Glu-Ser-Gln-Asn-Gln-Gln-Glu-Lys-Asn-
Glu-Gln-Glu-Leu-Leu-Glu-Leu-Asp-Lys
-Trp-Ala-Ser-Leu-Trp-Asn-Trp-Phe-NH2 | Cas No. | 159519-65-0 | Molecular Formula | C204H301N51O64 | Molecular Weight | 4492 | Purity (HPLC) | 98.0%min. | Appearance | White to off-white amorphous solid | Single Impurity (HPLC) | 0.5%max | Amino Acid Composition | ±10% of theoretical | Peptide Content (N%) | ≥80.0% | Water Content (Karl Fischer) | ≤8.0% | TrifluoroAcetate Content(HPIC) | ≤12.0% | MS (ESI) | Consistent | Mass Balance | 95.0~105.0% |
|
|
|
|
|
|
|
|
With more than 20 years of experience in solid-phase peptide synthesis, SBS Genetech is recognized as one of the global major leading industry players in Peptide Synthesis by third-party market researchers. For more details, please visit Peptide Synthesis Market 2017-2022 International Outlook, Trends and Analysis.
Only for research and not intended for treatment of humans or animals
